Related keylists
Strides Pharma Science Clinical Trials
Determine Strides Pharma Science Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Strides Pharma Science Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| An Open-label, Balanced, Randomized, Two-treatment, Two-sequence, Two-period, Two Way Cross-over, Single Dose Oral Bioequivalence Study Comparing Dolutegravir Tablets 50mg of Strides Shasun Limited with Tivicay (Dolutegravir) Tablets 50mg of Viiv Health Care in Healthy, Adult, Human Subjects under Fasting Conditions | GDCT0473313 | dolutegravir | Infectious Disease | Human Immunodeficiency Virus (HIV) Infections (AIDS) | Phase I | Completed | Strides Pharma Science Ltd |
| Open-label, Randomized, Cross-over, Two-stage, Single-centre Comparison Study of the Bioequivalence of Ibuprofen, 200 Mg Capsules, from Strides Shasun Limited, India and Nurofen Express, 200 Mg Capsules, from Pateon Softgels B.V., The Netherlands in Healthy Volunteers after a Single Dose on an Empty Stomach | GDCT0466469 | ibuprofen | Central Nervous System; Ear Nose Throat Disorders; Musculoskeletal Disorders; Women's Health | Arthritis Pain; Back Pain; Dental Pain (Toothache/Tooth Pain); Dysmenorrhea; Lateral Epicondylitis(Tennis Elbow); Migraine; Myalgia (Muscle Pain); Nasopharyngitis (Common Cold); Neuropathic Pain (Neuralgia); Osteoarthritis Pain; Pain; Primary Dysmenorrhea; Rheumatoid Arthritis Pain; Sinusitis; Tension -Type Headache | Phase I | Withdrawn | Strides Pharma Science Ltd |
| An Open-label, Randomized, Cross-over, Single-center, Four-sequence, Two-sequence Comparative Study of the Pharmacokinetics and Bioequivalence of Oseltamivir, 75 Mg Capsule, Manufactured by Strides Shasun Limited, India, and Tamiflu, 75 Mg Capsule, Manufactured by F. Hoffmann-la Roche Ltd., Switzerland , in Healthy Volunteers after Administration on an Empty Stomach | GDCT0466306 | oseltamivir phosphate | Infectious Disease | Influenza A Virus, H1N1 Subtype Infections; Influenza A Virus, H3N2 Subtype Infections; Influenzavirus B Infections | Phase I | Withdrawn | Strides Pharma Science Ltd |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer